Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
BMC Medicine|February 12, 2020
Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trialAndrew F Auld, Tefera Agizew, Anikie Mathoma, et al.
BMC Infectious Diseases|December 15, 2018
Effectiveness of repellent delivered through village health volunteers on malaria incidence in villages in South-East Myanmar: a stepped-wedge cluster-randomised controlled trial protocolWin Han Oo, Julia C Cutts, Paul A Agius, et al.
Immunogenetics|September 5, 2003
Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West AfricaSarah J Campbell, Pardis Sabeti, Katherine Fielding, et al.
Plos One|June 29, 2018
Measuring wealth in rural communities: Lessons from the Sanitation, Hygiene, Infant Nutrition Efficacy (SHINE) trialBernard Chasekwa, John A Maluccio, Robert Ntozini, et al.
Wellcome Open Research|June 10, 2024
Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trialJayne Ellis, Laura Nsangi, Ananta Bangdiwala, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2006
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West AfricaKerrie Tosh, Sarah J Campbell, Katherine Fielding, et al.
The Lancet. Respiratory Medicine|November 19, 2023
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
PLOS Global Public Health|November 3, 2025
Integrated health checks as a person-centred approach to systematic screening of household tuberculosis contacts: A realist-informed mixed-methods studyClaire Jacqueline Calderwood, Edson Tawanda Marambire, Modester Ngwerume, et al.
The New England Journal of Medicine|December 22, 2022
A 24-Week, All-Oral Regimen for Rifampin-Resistant TuberculosisBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Plos One|March 28, 2008
Host genetic factors and vaccine-induced immunity to hepatitis B virus infectionBranwen J Hennig, Katherine Fielding, John Broxholme, et al.
Pageof 32